LyGenesis Receives FDA Clearance to Begin Phase 2a Trial of its Cell Therapy for Patients with ...

Retrieved on: 2020-12-30 13:30:00

Tags for this article:

Branches of biology

Biology

Regenerative biomedicine

Emerging technologies

Jim Mellon

Liver regeneration

Regenerative medicine

Cell therapy

LyGenesis Inc.

Michael Hufford

Click the tags to see associated articles and topics

LyGenesis Receives FDA Clearance to Begin Phase 2a Trial of its Cell Therapy for Patients with .... View article details on HISWAI: https://www.prnewswire.com/news-releases/lygenesis-receives-fda-clearance-to-begin-phase-2a-trial-of-its-cell-therapy-for-patients-with-end-stage-liver-disease-and-also-closes-11-million-convertible-debt-financing-301199042.html

Excerpt

LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient's lymph nodes to be used as bioreactors to ...

Article found on: www.prnewswire.com

View Original Article